Primary |
Arteriosclerosis |
37.5% |
Hypertension |
25.0% |
Lung Infection |
25.0% |
Type 1 Diabetes Mellitus |
12.5% |
|
|
Secondary |
Product Used For Unknown Indication |
21.5% |
Hypertension |
13.9% |
Lung Infection |
9.1% |
Erysipelas |
7.2% |
Drug Use For Unknown Indication |
6.2% |
Arteriosclerosis |
5.7% |
Arteriosclerosis Obliterans |
5.7% |
Pain |
5.3% |
Type 1 Diabetes Mellitus |
3.8% |
Arterial Disorder |
2.9% |
Prophylaxis |
2.9% |
Asthma |
1.9% |
Atrial Fibrillation |
1.9% |
Constipation |
1.9% |
Depression |
1.9% |
Insomnia |
1.9% |
Osteitis |
1.9% |
Cognitive Disorder |
1.4% |
Dyslipidaemia |
1.4% |
Iron Deficiency |
1.4% |
|
Renal Failure Acute |
28.2% |
Gastrointestinal Haemorrhage |
12.8% |
Urinary Incontinence |
10.3% |
Agranulocytosis |
5.1% |
Transaminases Increased |
5.1% |
Blood Alkaline Phosphatase Increased |
2.6% |
Cytolytic Hepatitis |
2.6% |
Electrolyte Imbalance |
2.6% |
Fall |
2.6% |
Gamma-glutamyltransferase Increased |
2.6% |
Gastric Ulcer Haemorrhage |
2.6% |
Hyponatraemia |
2.6% |
Hypophosphataemia |
2.6% |
Jaundice |
2.6% |
Myoclonus |
2.6% |
Pancytopenia |
2.6% |
Platelet Count Decreased |
2.6% |
Rib Fracture |
2.6% |
Tachycardia |
2.6% |
Urinary Tract Infection |
2.6% |
|
Concomitant |
Drug Use For Unknown Indication |
27.3% |
Hypertension |
18.1% |
Product Used For Unknown Indication |
7.8% |
Diabetes Mellitus |
6.4% |
Type 2 Diabetes Mellitus |
5.2% |
Myocardial Infarction |
4.5% |
Unevaluable Event |
3.1% |
Hiv Infection |
3.0% |
Osteitis |
2.6% |
Cardiac Failure |
2.4% |
Dementia |
2.4% |
Osteoporosis |
2.3% |
Hepatitis C |
2.1% |
Induction Of Anaesthesia |
2.1% |
Depression |
1.9% |
Diabetes Mellitus Non-insulin-dependent |
1.9% |
Prophylaxis |
1.9% |
Device Therapy |
1.7% |
Arteritis |
1.6% |
Bronchopneumopathy |
1.6% |
|
Renal Failure |
11.2% |
Thrombocytopenia |
10.2% |
Rhabdomyolysis |
7.1% |
Tremor |
7.1% |
Hyponatraemia |
6.1% |
Vomiting |
6.1% |
Pain In Extremity |
5.1% |
Renal Failure Acute |
5.1% |
Sternal Fracture |
5.1% |
Malaise |
4.1% |
Syncope |
4.1% |
Toxic Skin Eruption |
4.1% |
International Normalised Ratio Increased |
3.1% |
Leukocytoclastic Vasculitis |
3.1% |
Meningitis Bacterial |
3.1% |
Nausea |
3.1% |
Pharmaceutical Product Complaint |
3.1% |
Pulmonary Embolism |
3.1% |
Rash Pustular |
3.1% |
Sepsis |
3.1% |
|